首页 > 最新文献

Cancer Informatics最新文献

英文 中文
Diagnostic Value of hTERT mRNA and in Combination With AFP, AFP-L3%, Des-γ-carboxyprothrombin for Screening of Hepatocellular Carcinoma in Liver Cirrhosis Patients HBV or HCV-Related hTERT mRNA及与AFP、AFP-L3%、Des-γ-羧基凝血酶原联合检测对筛查HBV或HCV相关肝硬化患者肝细胞癌的诊断价值
IF 2 Q2 MATHEMATICAL & COMPUTATIONAL BIOLOGY Pub Date : 2022-01-01 DOI: 10.1177/11769351221100730
Hoang Bac Nguyen, Xuan Thi Thanh Le, Huy Huu Nguyen, Thanh Thanh Vo, M. Le, Ngan Nguyen, Thien Minh Do-Nguyen, Cong Minh Truong-Nguyen, Bang Suong Thi Nguyen
Diagnosis of hepatocellular carcinoma (HCC) in early-stage, to give an effective treatment option and improve quality of life for cancer patients, is an important medical mission globally. Combination of AFP with some biomarkers may be more supportive in both diagnosis and screening of HCC, but the range value of these markers can be applied as daily markers were unclearly. In some studies, human telomerase reverse transcriptase (hTERT mRNA) was reported as an advantage marker to diagnose cancer. The present study identified serum of 340 patients that were infected chronic hepatitis B virus or hepatitis C virus and divided in 2 groups including Hepatocellular carcinoma (HCC) and liver cirrhosis (LC) to measure their values of hTERT mRNA, AFP, AFP-L3%, and DCP, as well as combination of them. As a result, the concentration of hTERT mRNA, AFP, AFP-L3%, and DCP in HCC groups were significantly higher than that in LC group (P < .01). For detecting HCC, hTERT mRNA had sensitivity of 88% and specificity of 96% (at the cutoff value of 31.5 copies/mL), AFP sensitivity of 73% and specificity of 92% (at the cutoff value of 5.1 ng/mL), AFP-L3% sensitivity of 69% and specificity of 90% (at the cutoff value of 1.05%), DCP sensitivity of 82% and specificity of 92% (at the cutoff value of 29.01 mAU/mL). The largest area under the curve (AUC) of combination hTERT mRNA with DCP was 0.932 (sensitivity of 98.2% and specificity of 88.2%). New combination of DCP with hTERT mRNA gave a useful choice for screening of HCC in chronic HBV or HCV patients associated liver cirrhosis.
肝癌的早期诊断,为癌症患者提供有效的治疗选择,提高患者的生活质量,是全球重要的医学使命。AFP联合一些生物标志物可能对HCC的诊断和筛查更有支持作用,但这些标志物是否可以作为日常标志物应用的范围值尚不清楚。在一些研究中,人类端粒酶逆转录酶(hTERT mRNA)被报道为诊断癌症的有利标志物。本研究对340例慢性乙型肝炎病毒或丙型肝炎病毒感染患者进行血清检测,将其分为肝细胞癌(HCC)组和肝硬化(LC)组,测定其hTERT mRNA、AFP、AFP- l3%、DCP及其联合含量。HCC组hTERT mRNA、AFP、AFP- l3%、DCP浓度均显著高于LC组(P < 0.01)。hTERT mRNA检测HCC的敏感性为88%,特异性为96%(临界值为31.5 copies/mL), AFP敏感性为73%,特异性为92%(临界值为5.1 ng/mL), AFP- l3%敏感性为69%,特异性为90%(临界值为1.05%),DCP敏感性为82%,特异性为92%(临界值为29.01 mAU/mL)。hTERT mRNA联合DCP的最大曲线下面积(AUC)为0.932,敏感性为98.2%,特异性为88.2%。DCP与hTERT mRNA的新组合为慢性HBV或HCV患者相关肝硬化的HCC筛查提供了有用的选择。
{"title":"Diagnostic Value of hTERT mRNA and in Combination With AFP, AFP-L3%, Des-γ-carboxyprothrombin for Screening of Hepatocellular Carcinoma in Liver Cirrhosis Patients HBV or HCV-Related","authors":"Hoang Bac Nguyen, Xuan Thi Thanh Le, Huy Huu Nguyen, Thanh Thanh Vo, M. Le, Ngan Nguyen, Thien Minh Do-Nguyen, Cong Minh Truong-Nguyen, Bang Suong Thi Nguyen","doi":"10.1177/11769351221100730","DOIUrl":"https://doi.org/10.1177/11769351221100730","url":null,"abstract":"Diagnosis of hepatocellular carcinoma (HCC) in early-stage, to give an effective treatment option and improve quality of life for cancer patients, is an important medical mission globally. Combination of AFP with some biomarkers may be more supportive in both diagnosis and screening of HCC, but the range value of these markers can be applied as daily markers were unclearly. In some studies, human telomerase reverse transcriptase (hTERT mRNA) was reported as an advantage marker to diagnose cancer. The present study identified serum of 340 patients that were infected chronic hepatitis B virus or hepatitis C virus and divided in 2 groups including Hepatocellular carcinoma (HCC) and liver cirrhosis (LC) to measure their values of hTERT mRNA, AFP, AFP-L3%, and DCP, as well as combination of them. As a result, the concentration of hTERT mRNA, AFP, AFP-L3%, and DCP in HCC groups were significantly higher than that in LC group (P < .01). For detecting HCC, hTERT mRNA had sensitivity of 88% and specificity of 96% (at the cutoff value of 31.5 copies/mL), AFP sensitivity of 73% and specificity of 92% (at the cutoff value of 5.1 ng/mL), AFP-L3% sensitivity of 69% and specificity of 90% (at the cutoff value of 1.05%), DCP sensitivity of 82% and specificity of 92% (at the cutoff value of 29.01 mAU/mL). The largest area under the curve (AUC) of combination hTERT mRNA with DCP was 0.932 (sensitivity of 98.2% and specificity of 88.2%). New combination of DCP with hTERT mRNA gave a useful choice for screening of HCC in chronic HBV or HCV patients associated liver cirrhosis.","PeriodicalId":35418,"journal":{"name":"Cancer Informatics","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46634427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
A 25 Immune-Related Gene Pair Signature Predicts Overall Survival in Cervical Cancer 25个免疫相关基因对标记可预测宫颈癌患者的总生存率
IF 2 Q2 MATHEMATICAL & COMPUTATIONAL BIOLOGY Pub Date : 2022-01-01 DOI: 10.1177/11769351221090921
Huaqiu Chen, Huanyu Xie, Pengyu Wang, S. Yan, Yuanyuan Zhang, Guangming Wang
Mounting evidence suggests that the tumor microenvironment plays an important role in the occurrence and development of cancer, with immune system dysfunction being closely related to malignant cancers. We aimed to screen immune-related genes (IRGs) to generate an IRG pair (IRGP)-based prognostic signature for cervical cancer (CC). Datasets were obtained from The Cancer Genome Atlas and Gene Expression Omnibus databases and used as training and validation cohorts, respectively. Using the ImmPort database, IRGs in control and CC samples were compared, and differentially expressed genes were identified to construct an IRGP prognostic signature. Based on this analysis, 25 IRGPs were identified as important factors for the prognosis of CC. Univariate and multivariate Cox regression analyses further showed that the IRGP signature was an independent prognostic factor of overall survival. In summary, we successfully constructed an IRGP prognostic signature of CC, providing insights into immunotherapy for CC.
越来越多的证据表明,肿瘤微环境在癌症的发生和发展中起着重要作用,免疫系统功能障碍与恶性肿瘤密切相关。我们旨在筛选免疫相关基因(IRG),以产生基于IRG对(IRGP)的宫颈癌症(CC)预后标志。数据集来自癌症基因组图谱和基因表达综合数据库,分别用作训练和验证队列。使用ImmPort数据库,比较对照和CC样本中的IRG,并鉴定差异表达基因以构建IRGP预后标志。基于这一分析,25个IRGP被确定为CC预后的重要因素。单变量和多变量Cox回归分析进一步表明,IRGP特征是影响总生存率的独立预后因素。总之,我们成功构建了CC的IRGP预后标志,为CC的免疫治疗提供了见解。
{"title":"A 25 Immune-Related Gene Pair Signature Predicts Overall Survival in Cervical Cancer","authors":"Huaqiu Chen, Huanyu Xie, Pengyu Wang, S. Yan, Yuanyuan Zhang, Guangming Wang","doi":"10.1177/11769351221090921","DOIUrl":"https://doi.org/10.1177/11769351221090921","url":null,"abstract":"Mounting evidence suggests that the tumor microenvironment plays an important role in the occurrence and development of cancer, with immune system dysfunction being closely related to malignant cancers. We aimed to screen immune-related genes (IRGs) to generate an IRG pair (IRGP)-based prognostic signature for cervical cancer (CC). Datasets were obtained from The Cancer Genome Atlas and Gene Expression Omnibus databases and used as training and validation cohorts, respectively. Using the ImmPort database, IRGs in control and CC samples were compared, and differentially expressed genes were identified to construct an IRGP prognostic signature. Based on this analysis, 25 IRGPs were identified as important factors for the prognosis of CC. Univariate and multivariate Cox regression analyses further showed that the IRGP signature was an independent prognostic factor of overall survival. In summary, we successfully constructed an IRGP prognostic signature of CC, providing insights into immunotherapy for CC.","PeriodicalId":35418,"journal":{"name":"Cancer Informatics","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47389905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
TULIP: An RNA-seq-based Primary Tumor Type Prediction Tool Using Convolutional Neural Networks. TULIP:使用卷积神经网络的基于rna序列的原发性肿瘤类型预测工具。
IF 2 Q2 MATHEMATICAL & COMPUTATIONAL BIOLOGY Pub Date : 2022-01-01 DOI: 10.1177/11769351221139491
Sara Jones, Matthew Beyers, Maulik Shukla, Fangfang Xia, Thomas Brettin, Rick Stevens, M Ryan Weil, Satishkumar Ranganathan Ganakammal

Background: With cancer as one of the leading causes of death worldwide, accurate primary tumor type prediction is critical in identifying genetic factors that can inhibit or slow tumor progression. There have been efforts to categorize primary tumor types with gene expression data using machine learning, and more recently with deep learning, in the last several years.

Methods: In this paper, we developed four 1-dimensional (1D) Convolutional Neural Network (CNN) models to classify RNA-seq count data as one of 17 highly represented primary tumor types or 32 primary tumor types regardless of imbalanced representation. Additionally, we adapted the models to take as input either all Ensembl genes (60,483) or protein coding genes only (19,758). Unlike previous work, we avoided selection bias by not filtering genes based on expression values. RNA-seq count data expressed as FPKM-UQ of 9,025 and 10,940 samples from The Cancer Genome Atlas (TCGA) were downloaded from the Genomic Data Commons (GDC) corresponding to 17 and 32 primary tumor types respectively for training and validating the models.

Results: All 4 1D-CNN models had an overall accuracy of 94.7% to 97.6% on the test dataset. Further evaluation indicates that the models with protein coding genes only as features performed with better accuracy compared to the models with all Ensembl genes for both 17 and 32 primary tumor types. For all models, the accuracy by primary tumor type was above 80% for most primary tumor types.

Conclusions: We packaged all 4 models as a Python-based deep learning classification tool called TULIP (TUmor CLassIfication Predictor) for performing quality control on primary tumor samples and characterizing cancer samples of unknown tumor type. Further optimization of the models is needed to improve the accuracy of certain primary tumor types.

背景:癌症是世界范围内导致死亡的主要原因之一,准确的原发肿瘤类型预测对于确定能够抑制或减缓肿瘤进展的遗传因素至关重要。在过去的几年里,人们一直在努力利用机器学习和深度学习的基因表达数据对原发性肿瘤类型进行分类。方法:在本文中,我们开发了四个一维卷积神经网络(CNN)模型,将RNA-seq计数数据分类为17种高度代表性的原发肿瘤类型之一或32种原发肿瘤类型,而不考虑不平衡的代表性。此外,我们调整了模型,将所有的Ensembl基因(60,483)或蛋白质编码基因(19,758)作为输入。与之前的工作不同,我们没有根据表达值过滤基因,从而避免了选择偏差。从基因组数据共享(GDC)下载来自癌症基因组图谱(TCGA)的9,025和10,940个样本的RNA-seq计数数据,分别对应17和32种原发肿瘤类型,以FPKM-UQ表示,用于训练和验证模型。结果:4个1D-CNN模型在测试数据集上的总体准确率为94.7% ~ 97.6%。进一步的评估表明,在17种和32种原发肿瘤类型中,仅以蛋白质编码基因为特征的模型比包含所有Ensembl基因的模型具有更好的准确性。对于所有模型,大多数原发肿瘤类型的准确率都在80%以上。结论:我们将所有4个模型打包成一个基于python的深度学习分类工具TULIP (TUmor classification Predictor),用于对原发肿瘤样本进行质量控制,并对未知肿瘤类型的癌症样本进行表征。需要进一步优化模型以提高某些原发肿瘤类型的准确性。
{"title":"TULIP: An RNA-seq-based Primary Tumor Type Prediction Tool Using Convolutional Neural Networks.","authors":"Sara Jones,&nbsp;Matthew Beyers,&nbsp;Maulik Shukla,&nbsp;Fangfang Xia,&nbsp;Thomas Brettin,&nbsp;Rick Stevens,&nbsp;M Ryan Weil,&nbsp;Satishkumar Ranganathan Ganakammal","doi":"10.1177/11769351221139491","DOIUrl":"https://doi.org/10.1177/11769351221139491","url":null,"abstract":"<p><strong>Background: </strong>With cancer as one of the leading causes of death worldwide, accurate primary tumor type prediction is critical in identifying genetic factors that can inhibit or slow tumor progression. There have been efforts to categorize primary tumor types with gene expression data using machine learning, and more recently with deep learning, in the last several years.</p><p><strong>Methods: </strong>In this paper, we developed four 1-dimensional (1D) Convolutional Neural Network (CNN) models to classify RNA-seq count data as one of 17 highly represented primary tumor types or 32 primary tumor types regardless of imbalanced representation. Additionally, we adapted the models to take as input either all Ensembl genes (60,483) or protein coding genes only (19,758). Unlike previous work, we avoided selection bias by not filtering genes based on expression values. RNA-seq count data expressed as FPKM-UQ of 9,025 and 10,940 samples from The Cancer Genome Atlas (TCGA) were downloaded from the Genomic Data Commons (GDC) corresponding to 17 and 32 primary tumor types respectively for training and validating the models.</p><p><strong>Results: </strong>All 4 1D-CNN models had an overall accuracy of 94.7% to 97.6% on the test dataset. Further evaluation indicates that the models with protein coding genes only as features performed with better accuracy compared to the models with all Ensembl genes for both 17 and 32 primary tumor types. For all models, the accuracy by primary tumor type was above 80% for most primary tumor types.</p><p><strong>Conclusions: </strong>We packaged all 4 models as a Python-based deep learning classification tool called TULIP (TUmor CLassIfication Predictor) for performing quality control on primary tumor samples and characterizing cancer samples of unknown tumor type. Further optimization of the models is needed to improve the accuracy of certain primary tumor types.</p>","PeriodicalId":35418,"journal":{"name":"Cancer Informatics","volume":"21 ","pages":"11769351221139491"},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b1/0b/10.1177_11769351221139491.PMC9729992.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10333449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Bioinformatics Analysis of Differential Gene and MicroRNA Expression in Lung Adenocarcinoma: Genetic Effects on Patient Prognosis, as Indicated by the TCGA Database 肺腺癌差异基因和微小RNA表达的生物信息学分析:TCGA数据库显示的基因对患者预后的影响
IF 2 Q2 MATHEMATICAL & COMPUTATIONAL BIOLOGY Pub Date : 2022-01-01 DOI: 10.1177/11769351221082020
Bingqing Sun, Hongwen Zhao
Objective: To investigate the differential expression of genes and microRNAs (miRNAs) in patients with lung adenocarcinoma and the relationship between such changes and patient prognosis. Methods: We analyzed the expression levels of genes and miRNAs in lung adenocarcinoma tissues and adjacent normal tissues using The Cancer Genome Atlas database (TCGA). We analyzed the function of the differentially expressed genes and miRNAs in a co-expression network. Finally, we performed survival analysis of differential genes and miRNAs in the co-expression network using clinical data from the TCGA database. Results: We successfully identified 6064 differentially expressed genes: 5324 upregulated genes and 740 downregulated genes. And we identified 161 differentially expressed miRNAs: 126 upregulated miRNAs and 35 downregulated miRNAs. We identified several genes that were related to each other in the co-expression network. Further analysis revealed that the high expression levels of G6PC, APOB, F2, PAQR9, and PAQR9-AS1 genes were associated with poor prognosis. However, there was no significant correlation between the expression of hsa-mir-122 with regards to patient prognosis. Conclusions: Our data showed that hsa-mir-122 and a number of related genes may affect the prognosis of patients with lung adenocarcinoma by regulating the cytoskeleton, thus promoting tumor angiogenesis and the metastasis of tumor cells. The high expression levels of some differentially expressed genes was associated with the low survival rate in patients with lung adenocarcinoma. However, the levels of hsa-mir-122 were not correlated with patient prognosis.
目的:探讨肺腺癌患者基因和微小RNA(miRNA)的差异表达及其与预后的关系。方法:我们使用癌症基因组图谱数据库(TCGA)分析了肺腺癌组织和邻近正常组织中基因和miRNA的表达水平。我们分析了差异表达基因和miRNA在共表达网络中的功能。最后,我们使用来自TCGA数据库的临床数据对共表达网络中的差异基因和miRNA进行了生存分析。结果:我们成功鉴定了6064个差异表达基因:5324个上调基因和740个下调基因。我们鉴定了161种差异表达的miRNA:126种上调的miRNA和35种下调的miRNA。我们在共表达网络中鉴定了几个相互关联的基因。进一步分析显示,G6PC、APOB、F2、PAQR9和PAQR9-AS1基因的高表达水平与预后不良有关。然而,hsa-mir-122的表达与患者预后之间没有显著相关性。结论:我们的数据表明,hsa-mir-122和一些相关基因可能通过调节细胞骨架来影响肺腺癌患者的预后,从而促进肿瘤血管生成和肿瘤细胞的转移。一些差异表达基因的高表达水平与肺腺癌患者的低生存率有关。然而,hsa-mir-122水平与患者预后无关。
{"title":"Bioinformatics Analysis of Differential Gene and MicroRNA Expression in Lung Adenocarcinoma: Genetic Effects on Patient Prognosis, as Indicated by the TCGA Database","authors":"Bingqing Sun, Hongwen Zhao","doi":"10.1177/11769351221082020","DOIUrl":"https://doi.org/10.1177/11769351221082020","url":null,"abstract":"Objective: To investigate the differential expression of genes and microRNAs (miRNAs) in patients with lung adenocarcinoma and the relationship between such changes and patient prognosis. Methods: We analyzed the expression levels of genes and miRNAs in lung adenocarcinoma tissues and adjacent normal tissues using The Cancer Genome Atlas database (TCGA). We analyzed the function of the differentially expressed genes and miRNAs in a co-expression network. Finally, we performed survival analysis of differential genes and miRNAs in the co-expression network using clinical data from the TCGA database. Results: We successfully identified 6064 differentially expressed genes: 5324 upregulated genes and 740 downregulated genes. And we identified 161 differentially expressed miRNAs: 126 upregulated miRNAs and 35 downregulated miRNAs. We identified several genes that were related to each other in the co-expression network. Further analysis revealed that the high expression levels of G6PC, APOB, F2, PAQR9, and PAQR9-AS1 genes were associated with poor prognosis. However, there was no significant correlation between the expression of hsa-mir-122 with regards to patient prognosis. Conclusions: Our data showed that hsa-mir-122 and a number of related genes may affect the prognosis of patients with lung adenocarcinoma by regulating the cytoskeleton, thus promoting tumor angiogenesis and the metastasis of tumor cells. The high expression levels of some differentially expressed genes was associated with the low survival rate in patients with lung adenocarcinoma. However, the levels of hsa-mir-122 were not correlated with patient prognosis.","PeriodicalId":35418,"journal":{"name":"Cancer Informatics","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44965393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
An In Silico Analysis Reveals an EMT-Associated Gene Signature for Predicting Recurrence of Early-Stage Lung Adenocarcinoma 硅内分析揭示EMT相关基因特征预测早期肺腺癌复发
IF 2 Q2 MATHEMATICAL & COMPUTATIONAL BIOLOGY Pub Date : 2022-01-01 DOI: 10.1177/11769351221100727
Yi Han, F. Wong, Di Wang, C. Kahlert
Background: The potential micrometastasis tends to cause recurrence of lung adenocarcinoma (LUAD) after surgical resection and consequently leads to an increase in the mortality risk. Compelling evidence has suggested the underlying mechanisms of tumor metastasis could involve the activation of an epithelial-mesenchymal transition (EMT) program. Hence, the objective of this study was to develop an EMT-associated gene signature for predicting the recurrence of early-stage LUAD. Methods: The mRNA expression data of patients with early-stage LUAD were downloaded from Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) available databases. Gene Set Variation Analysis (GSVA) was first performed to provide an assessment of EMT phenotype, whereas Weighted Gene Co-expression Network Analysis (WGCNA) was constructed to determine EMT-associated key modules and genes. Based on the genes, a novel EMT-associated signature for predicting the recurrence of early-stage LUAD was identified using a least absolute shrinkage and selection operator (LASSO) algorithm and a stepwise Cox proportional hazards regression model. Kaplan-Meier survival analysis, receiver operating characteristic (ROC) curves and Cox regression analyses were used to estimate the performance of the identified gene signature. Results: GSVA revealed diverse EMT states in the early-stage LUAD. Further correlation analyses showed that the EMT states presented high correlations with several hallmarks of cancers, tumor purity, tumor microenvironment cells, and immune checkpoint genes. More importantly, Kaplan-Meier survival analyses indicated that patients with high EMT scores had worse recurrence-free survival (RFS) and overall survival (OS) than those with low EMT scores. A novel 5-gene signature (AGL, ECM1, ENPP1, SNX7, and TSPAN12) was established based on the EMT-associated genes from WGCNA and this signature successfully predicted that the high-risk patients had a higher recurrence rate compared with the low-risk patients. In further analyses, the signature represented robust prognostic values in 2 independent validation cohorts (GEO and TCGA datasets) and a combined GEO cohort as evaluated by Kaplan-Meier survival (P-value < .0001) and ROC analysis (AUC = 0.781). Moreover, the signature was corroborated to be independent of clinical factors by univariate and multivariate Cox regression analyses. Interestingly, the combination of the signature-based recurrence risk and tumor-node-metastasis (TNM) stage showed a superior predictive ability on the recurrence of patients with early-stage LUAD. Conclusion: Our study suggests that patients with early-stage LUAD exhibit diverse EMT states that play a vital role in tumor recurrence. The novel and promising EMT-associated 5-gene signature identified and validated in this study may be applied to predict the recurrence of early-stage LUAD, facilitating risk stratification, recurrence monitoring, and individualized management for the patient
背景:潜在的微转移往往会导致肺腺癌(LUAD)手术切除后复发,从而导致死亡风险增加。令人信服的证据表明,肿瘤转移的潜在机制可能涉及上皮-间充质转化(EMT)程序的激活。因此,本研究的目的是开发一种EMT相关基因标记,用于预测早期LUAD的复发。方法:从基因表达综合数据库(GEO)和癌症基因组图谱(TCGA)中下载早期LUAD患者的mRNA表达数据。基因集变异分析(GSVA)首先用于评估EMT表型,而加权基因共表达网络分析(WGCNA)用于确定EMT相关的关键模块和基因。基于这些基因,使用最小绝对收缩和选择算子(LASSO)算法和逐步Cox比例风险回归模型,确定了一种用于预测早期LUAD复发的新的EMT相关特征。Kaplan-Meier生存分析、受试者操作特征(ROC)曲线和Cox回归分析用于评估已鉴定基因特征的性能。结果:GSVA在早期LUAD中显示出不同的EMT状态。进一步的相关性分析表明,EMT状态与癌症的几个特征、肿瘤纯度、肿瘤微环境细胞和免疫检查点基因高度相关。更重要的是,Kaplan-Meier生存率分析表明,EMT评分高的患者无复发生存率(RFS)和总生存率(OS)比EMT评分低的患者差。基于WGCNA的EMT相关基因,建立了一种新的5基因标记(AGL、ECM1、ENPP1、SNX7和TSPAN12),该标记成功地预测了高危患者与低危患者相比具有更高的复发率。在进一步的分析中,该特征在2个独立验证队列(GEO和TCGA数据集)和Kaplan-Meier生存率评估的组合GEO队列中代表了稳健的预后值(P值 < .0001)和ROC分析(AUC = 0.781)。此外,通过单变量和多变量Cox回归分析证实,该特征与临床因素无关。有趣的是,基于特征的复发风险和肿瘤淋巴结转移(TNM)分期的组合对早期LUAD患者的复发显示出优越的预测能力。结论:我们的研究表明,早期LUAD患者表现出不同的EMT状态,这在肿瘤复发中起着至关重要的作用。本研究中确定并验证的新型且有前景的EMT相关5基因特征可用于预测早期LUAD的复发,促进风险分层、复发监测和手术切除后患者的个体化管理。
{"title":"An In Silico Analysis Reveals an EMT-Associated Gene Signature for Predicting Recurrence of Early-Stage Lung Adenocarcinoma","authors":"Yi Han, F. Wong, Di Wang, C. Kahlert","doi":"10.1177/11769351221100727","DOIUrl":"https://doi.org/10.1177/11769351221100727","url":null,"abstract":"Background: The potential micrometastasis tends to cause recurrence of lung adenocarcinoma (LUAD) after surgical resection and consequently leads to an increase in the mortality risk. Compelling evidence has suggested the underlying mechanisms of tumor metastasis could involve the activation of an epithelial-mesenchymal transition (EMT) program. Hence, the objective of this study was to develop an EMT-associated gene signature for predicting the recurrence of early-stage LUAD. Methods: The mRNA expression data of patients with early-stage LUAD were downloaded from Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) available databases. Gene Set Variation Analysis (GSVA) was first performed to provide an assessment of EMT phenotype, whereas Weighted Gene Co-expression Network Analysis (WGCNA) was constructed to determine EMT-associated key modules and genes. Based on the genes, a novel EMT-associated signature for predicting the recurrence of early-stage LUAD was identified using a least absolute shrinkage and selection operator (LASSO) algorithm and a stepwise Cox proportional hazards regression model. Kaplan-Meier survival analysis, receiver operating characteristic (ROC) curves and Cox regression analyses were used to estimate the performance of the identified gene signature. Results: GSVA revealed diverse EMT states in the early-stage LUAD. Further correlation analyses showed that the EMT states presented high correlations with several hallmarks of cancers, tumor purity, tumor microenvironment cells, and immune checkpoint genes. More importantly, Kaplan-Meier survival analyses indicated that patients with high EMT scores had worse recurrence-free survival (RFS) and overall survival (OS) than those with low EMT scores. A novel 5-gene signature (AGL, ECM1, ENPP1, SNX7, and TSPAN12) was established based on the EMT-associated genes from WGCNA and this signature successfully predicted that the high-risk patients had a higher recurrence rate compared with the low-risk patients. In further analyses, the signature represented robust prognostic values in 2 independent validation cohorts (GEO and TCGA datasets) and a combined GEO cohort as evaluated by Kaplan-Meier survival (P-value &lt; .0001) and ROC analysis (AUC = 0.781). Moreover, the signature was corroborated to be independent of clinical factors by univariate and multivariate Cox regression analyses. Interestingly, the combination of the signature-based recurrence risk and tumor-node-metastasis (TNM) stage showed a superior predictive ability on the recurrence of patients with early-stage LUAD. Conclusion: Our study suggests that patients with early-stage LUAD exhibit diverse EMT states that play a vital role in tumor recurrence. The novel and promising EMT-associated 5-gene signature identified and validated in this study may be applied to predict the recurrence of early-stage LUAD, facilitating risk stratification, recurrence monitoring, and individualized management for the patient","PeriodicalId":35418,"journal":{"name":"Cancer Informatics","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49035005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Deciphering the Increased Prevalence of TP53 Mutations in Metastatic Prostate Cancer 解读转移性前列腺癌中TP53突变增加的患病率
IF 2 Q2 MATHEMATICAL & COMPUTATIONAL BIOLOGY Pub Date : 2022-01-01 DOI: 10.1177/11769351221087046
Wensheng Zhang, Yan Dong, O. Sartor, Kun Zhang
The prevalence of TP53 mutations in advanced prostate cancers (PCa) is 3 to 5 times of the quantity in primary PCa. By an integrative analysis of the Cancer Genome Atlas and Catalogue of Somatic Mutations in Cancer data, we revealed the supporting evidence for 2 complementary hypotheses: H1 - TP53 abnormalities promote metastasis or therapy-resistance of PCa cells, and H2—part of TP53 mutations in PCa metastases occur after the diagnosis of original cancers. The plausibility of these hypotheses can explain the increased prevalence of TP53 mutations in PCa metastases. With H1 and H2 as the general assumptions, we developed mathematical models to decipher the change of the percentage frequency (prevalence) of TP53 mutations from primary tumors to metastases. The following results were obtained. Compared to TP53-normal patients, TP53-mutated patients had poorer biochemical relapse-free survival, higher Gleason scores, and more advanced t-stages (P < .01). Single-nucleotide variants in metastases more frequently occurred on G bases of the coding sequence than those in primary cancers (P = .03). The profile of TP53 hotspot mutations was significantly different between primary and metastatic PCa as demonstrated in a set of statistical tests (P < .05). By the derived formulae, we estimated that about 40% TP53 mutation records collected from metastases occurred after the diagnosis of the original cancers. Our study provided significant insight into PCa progression. The proposed models can also be applied to decipher the prevalence of mutations on TP53 (or other driver genes) in other cancer types.
晚期前列腺癌(PCa)中TP53突变的发生率是原发性前列腺癌的3-5倍。通过对癌症基因组图谱和癌症体细胞突变目录数据的综合分析,我们揭示了两个互补假设的支持证据:H1-TP53异常促进PCa细胞的转移或耐药性,而PCa转移中TP53的H2-部分突变发生在原发癌症诊断后。这些假设的合理性可以解释前列腺癌转移中TP53突变发生率的增加。以H1和H2为一般假设,我们开发了数学模型来解读TP53突变从原发肿瘤到转移瘤的百分比频率(患病率)的变化。获得以下结果。与TP53正常患者相比,TP53突变患者的生化无复发生存率较差,Gleason评分较高,t分期更晚期(P < .01)。转移癌中的单核苷酸变异发生在编码序列的G碱基上的频率高于原发癌(P = .03)。TP53热点突变在原发性和转移性前列腺癌之间有显著差异,如一组统计检验所示(P < .05)。根据推导的公式,我们估计从转移中收集的大约40%的TP53突变记录发生在诊断出原始癌症之后。我们的研究为前列腺癌的进展提供了重要的见解。所提出的模型也可用于解读其他癌症类型中TP53(或其他驱动基因)突变的流行率。
{"title":"Deciphering the Increased Prevalence of TP53 Mutations in Metastatic Prostate Cancer","authors":"Wensheng Zhang, Yan Dong, O. Sartor, Kun Zhang","doi":"10.1177/11769351221087046","DOIUrl":"https://doi.org/10.1177/11769351221087046","url":null,"abstract":"The prevalence of TP53 mutations in advanced prostate cancers (PCa) is 3 to 5 times of the quantity in primary PCa. By an integrative analysis of the Cancer Genome Atlas and Catalogue of Somatic Mutations in Cancer data, we revealed the supporting evidence for 2 complementary hypotheses: H1 - TP53 abnormalities promote metastasis or therapy-resistance of PCa cells, and H2—part of TP53 mutations in PCa metastases occur after the diagnosis of original cancers. The plausibility of these hypotheses can explain the increased prevalence of TP53 mutations in PCa metastases. With H1 and H2 as the general assumptions, we developed mathematical models to decipher the change of the percentage frequency (prevalence) of TP53 mutations from primary tumors to metastases. The following results were obtained. Compared to TP53-normal patients, TP53-mutated patients had poorer biochemical relapse-free survival, higher Gleason scores, and more advanced t-stages (P < .01). Single-nucleotide variants in metastases more frequently occurred on G bases of the coding sequence than those in primary cancers (P = .03). The profile of TP53 hotspot mutations was significantly different between primary and metastatic PCa as demonstrated in a set of statistical tests (P < .05). By the derived formulae, we estimated that about 40% TP53 mutation records collected from metastases occurred after the diagnosis of the original cancers. Our study provided significant insight into PCa progression. The proposed models can also be applied to decipher the prevalence of mutations on TP53 (or other driver genes) in other cancer types.","PeriodicalId":35418,"journal":{"name":"Cancer Informatics","volume":"21 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42356781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Single-Cell Transcriptome Analysis Reveals Paraspeckles Expression in Osteosarcoma Tissues. 单细胞转录组分析揭示骨肉瘤组织中的副斑表达。
IF 2 Q2 MATHEMATICAL & COMPUTATIONAL BIOLOGY Pub Date : 2022-01-01 DOI: 10.1177/11769351221140101
Emel Rothzerg, Wenyu Feng, Dezhi Song, Hengyuan Li, Qingjun Wei, Archa Fox, David Wood, Jiake Xu, Yun Liu

Nuclear paraspeckles are subnuclear bodies contracted by nuclear-enriched abundant transcript 1 (NEAT1) long non-coding RNA, localised in the interchromatin space of mammalian cell nuclei. Paraspeckles have been critically involved in tumour progression, metastasis and chemoresistance. To this date, there are limited findings to suggest that paraspeckles, NEAT1 and heterogeneous nuclear ribonucleoproteins (hnRNPs) directly or indirectly play roles in osteosarcoma progression. Herein, we analysed NEAT1, paraspeckle proteins (SFPQ, PSPC1 and NONO) and hnRNP members (HNRNPK, HNRNPM, HNRNPR and HNRNPD) gene expression in 6 osteosarcoma tumour tissues using the single-cell RNA-sequencing method. The normalised data highlighted that the paraspeckles transcripts were highly abundant in osteoblastic OS cells, except NEAT1, which was highly expressed in myeloid cell 1 and 2 subpopulations.

核副斑是由核富集丰富转录本1 (NEAT1)长链非编码RNA收缩的亚核小体,定位于哺乳动物细胞核的染色质间间隙。副斑在肿瘤进展、转移和化疗耐药中起关键作用。迄今为止,有有限的研究结果表明副斑、NEAT1和异质核核糖核蛋白(hnRNPs)直接或间接地在骨肉瘤的进展中起作用。本文采用单细胞rna测序方法分析了6例骨肉瘤肿瘤组织中NEAT1、副斑蛋白(SFPQ、PSPC1和NONO)和hnRNP成员(HNRNPK、HNRNPM、HNRNPR和HNRNPD)基因的表达。规范化数据强调,除了NEAT1在骨髓细胞1和2亚群中高度表达外,副斑转录物在成骨骨肉瘤细胞中高度丰富。
{"title":"Single-Cell Transcriptome Analysis Reveals Paraspeckles Expression in Osteosarcoma Tissues.","authors":"Emel Rothzerg,&nbsp;Wenyu Feng,&nbsp;Dezhi Song,&nbsp;Hengyuan Li,&nbsp;Qingjun Wei,&nbsp;Archa Fox,&nbsp;David Wood,&nbsp;Jiake Xu,&nbsp;Yun Liu","doi":"10.1177/11769351221140101","DOIUrl":"https://doi.org/10.1177/11769351221140101","url":null,"abstract":"<p><p>Nuclear paraspeckles are subnuclear bodies contracted by nuclear-enriched abundant transcript 1 (NEAT1) long non-coding RNA, localised in the interchromatin space of mammalian cell nuclei. Paraspeckles have been critically involved in tumour progression, metastasis and chemoresistance. To this date, there are limited findings to suggest that paraspeckles, NEAT1 and heterogeneous nuclear ribonucleoproteins (hnRNPs) directly or indirectly play roles in osteosarcoma progression. Herein, we analysed NEAT1, paraspeckle proteins (SFPQ, PSPC1 and NONO) and hnRNP members (HNRNPK, HNRNPM, HNRNPR and HNRNPD) gene expression in 6 osteosarcoma tumour tissues using the single-cell RNA-sequencing method. The normalised data highlighted that the paraspeckles transcripts were highly abundant in osteoblastic OS cells, except NEAT1, which was highly expressed in myeloid cell 1 and 2 subpopulations.</p>","PeriodicalId":35418,"journal":{"name":"Cancer Informatics","volume":"21 ","pages":"11769351221140101"},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4d/17/10.1177_11769351221140101.PMC9730017.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10333451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Knowledge, Attitude, and Practice Toward Cervical Cancer Screening and Associated Factors Among College and University Female Students in Dire Dawa City, Eastern Ethiopia 埃塞俄比亚东部迪勒达瓦市高校女生对宫颈癌筛查的知识、态度和行为及其相关因素
IF 2 Q2 MATHEMATICAL & COMPUTATIONAL BIOLOGY Pub Date : 2022-01-01 DOI: 10.1177/11769351221084808
H. Bekele, A. Nuri, Legesse Abera
Introduction: Cervical cancer is preventable and, in most cases, curable if identified at an early stage. Cervical cancer is the second leading cause of cancer-related mortality Ethiopia with screening accounting for only 0.8%. Furthermore, female students and young adults in colleges and universities’ have a high prevalence of genital HPV infection because of their risky sexual behavior, lack of knowledge on screening and very few students receive screening services. This study aimed to assess the Knowledge, attitudes, and practice toward cervical cancer screening and its associated factors among female college students in Dire Dawa City, Ethiopia. Methods: An institutional-based cross-sectional study was conducted using a multistage sampling technique from November to December 2020, among 730 female college students in Dire Dawa. Descriptive statistics and binary logistic regression were used to describe each variable and identify associations between the dependent and independent variables respectively. Adjusted odds ratio with 95% confidence interval and P-value <.05 used to determine the association. Results: The results showed, only 64 (9.3%) participants were knowledgeable, 413 (60.1%) had positive attitudes and 17 (2.5%) were screened in their lifetime. Age group, years of study, and history of cervical cancer practice were significantly associated with knowledge of cervical cancer screening. The year of study was based on cervical cancer smears and the number of screenings was significantly associated with attitude. Conclusion: This study showed that students’ knowledge of cervical cancer screening is low. Overall attitudes toward cervical cancer screening among female students were good, but only a small proportion of students had undergone cervical cancer screening. The most common reasons for the low screening practice were lack of information and undecided. There is a need to promote different campaigns for cervical cancer screening programs, in order to increase awareness.
简介:子宫颈癌是可以预防的,在大多数情况下,如果及早发现,是可以治愈的。子宫颈癌是埃塞俄比亚癌症相关死亡率的第二大原因,筛查率仅占0.8%。此外,高校的女学生和青年由于其危险性行为、缺乏筛查知识以及很少有学生接受筛查服务,生殖器HPV感染的患病率很高。本研究旨在评估埃塞俄比亚迪勒达瓦市女大学生对宫颈癌筛查的知识、态度、行为及其相关因素。方法:采用多阶段抽样方法,于2020年11月至12月对迪勒达瓦省730名女大学生进行基于机构的横断面研究。使用描述性统计和二元逻辑回归来描述每个变量,并分别确定因变量和自变量之间的关联。校正优势比,95%置信区间,p值<。05用于确定关联关系。结果:有知识的64人(9.3%),有积极态度的413人(60.1%),有终身筛查的17人(2.5%)。年龄、学习年限和宫颈癌诊疗史与宫颈癌筛查知识显著相关。研究的年份是基于宫颈癌涂片检查的,检查的次数与态度显著相关。结论:本研究显示学生对宫颈癌筛查的认知程度较低。女学生对子宫颈癌筛查的整体态度良好,但只有一小部分学生接受过子宫颈癌筛查。低筛查率的最常见原因是缺乏信息和犹豫不决。有必要开展不同的宫颈癌筛查活动,以提高人们的认识。
{"title":"Knowledge, Attitude, and Practice Toward Cervical Cancer Screening and Associated Factors Among College and University Female Students in Dire Dawa City, Eastern Ethiopia","authors":"H. Bekele, A. Nuri, Legesse Abera","doi":"10.1177/11769351221084808","DOIUrl":"https://doi.org/10.1177/11769351221084808","url":null,"abstract":"Introduction: Cervical cancer is preventable and, in most cases, curable if identified at an early stage. Cervical cancer is the second leading cause of cancer-related mortality Ethiopia with screening accounting for only 0.8%. Furthermore, female students and young adults in colleges and universities’ have a high prevalence of genital HPV infection because of their risky sexual behavior, lack of knowledge on screening and very few students receive screening services. This study aimed to assess the Knowledge, attitudes, and practice toward cervical cancer screening and its associated factors among female college students in Dire Dawa City, Ethiopia. Methods: An institutional-based cross-sectional study was conducted using a multistage sampling technique from November to December 2020, among 730 female college students in Dire Dawa. Descriptive statistics and binary logistic regression were used to describe each variable and identify associations between the dependent and independent variables respectively. Adjusted odds ratio with 95% confidence interval and P-value <.05 used to determine the association. Results: The results showed, only 64 (9.3%) participants were knowledgeable, 413 (60.1%) had positive attitudes and 17 (2.5%) were screened in their lifetime. Age group, years of study, and history of cervical cancer practice were significantly associated with knowledge of cervical cancer screening. The year of study was based on cervical cancer smears and the number of screenings was significantly associated with attitude. Conclusion: This study showed that students’ knowledge of cervical cancer screening is low. Overall attitudes toward cervical cancer screening among female students were good, but only a small proportion of students had undergone cervical cancer screening. The most common reasons for the low screening practice were lack of information and undecided. There is a need to promote different campaigns for cervical cancer screening programs, in order to increase awareness.","PeriodicalId":35418,"journal":{"name":"Cancer Informatics","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44368152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
In silico Prediction on the PI3K/AKT/mTOR Pathway of the Antiproliferative Effect of O. joconostle in Breast Cancer Models PI3K/AKT/mTOR通路在乳腺癌模型中抗增殖作用的计算机预测
IF 2 Q2 MATHEMATICAL & COMPUTATIONAL BIOLOGY Pub Date : 2022-01-01 DOI: 10.1177/11769351221087028
Alejandra Ortiz-González, P. P. González-Pérez, M. Cárdenas-García, M. Hernández-Linares
The search for new cancer treatments from traditional medicine involves developing studies to understand at the molecular level different cell signaling pathways involved in cancer development. In this work, we present a model of the PI3K/Akt/mTOR pathway, which plays a key role in cell cycle regulation and is related to cell survival, proliferation, and growth in cancer, as well as resistance to antitumor therapies, so finding drugs that act on this pathway is ideal to propose a new adjuvant treatment. The aim of this work was to model, simulate and predict in silico using the Big Data-Cellulat platform the possible targets in the PI3K/Akt/mTOR pathway on which the Opuntia joconostle extract acts, as well as to indicate the concentration range to be used to find the mean lethal dose in in vitro experiments on breast cancer cells. The in silico results show that, in a cancer cell, the activation of JAK and STAT, as well as PI3K and Akt is related to the effect of cell proliferation, angiogenesis, and inhibition of apoptosis, and that the extract of O. joconostle has an antiproliferative effect on breast cancer cells by inhibiting cell proliferation, regulating the cell cycle and inhibiting apoptosis through this signaling pathway. In vitro it was demonstrated that the extract shows an antiproliferative effect, causing the arrest of cells in the G2/M phase of the cell cycle. Therefore, it is concluded that the use of in silico tools is a valuable method to perform virtual experiments and discover new treatments. The use of this type of model supports in vitro experimentation, reducing the costs and number of experiments in the real laboratory.
从传统医学中寻找新的癌症治疗方法涉及开展研究,以在分子水平上了解参与癌症发展的不同细胞信号通路。在这项工作中,我们提出了PI3K/Akt/mTOR通路的模型,该通路在细胞周期调节中起着关键作用,与癌症的细胞存活、增殖和生长以及抗肿瘤治疗的耐药性有关,因此找到作用于该通路的药物是提出新的辅助治疗的理想选择。这项工作的目的是使用大数据细胞平台在计算机上建模、模拟和预测Opuntia joconostle提取物作用的PI3K/Akt/mTOR途径中的可能靶点,并指示用于在乳腺癌症细胞体外实验中寻找平均致死剂量的浓度范围。计算机模拟结果表明,在癌症细胞中,JAK和STAT以及PI3K和Akt的激活与细胞增殖、血管生成和抑制细胞凋亡的作用有关,并且O.joconostle提取物通过抑制细胞增殖对乳腺癌症细胞具有抗增殖作用,通过该信号通路调节细胞周期并抑制细胞凋亡。在体外,已经证明该提取物显示出抗增殖作用,导致细胞停滞在细胞周期的G2/M期。因此,得出的结论是,使用硅工具是进行虚拟实验和发现新治疗方法的一种有价值的方法。这种类型的模型的使用支持体外实验,减少了真实实验室中的实验成本和数量。
{"title":"In silico Prediction on the PI3K/AKT/mTOR Pathway of the Antiproliferative Effect of O. joconostle in Breast Cancer Models","authors":"Alejandra Ortiz-González, P. P. González-Pérez, M. Cárdenas-García, M. Hernández-Linares","doi":"10.1177/11769351221087028","DOIUrl":"https://doi.org/10.1177/11769351221087028","url":null,"abstract":"The search for new cancer treatments from traditional medicine involves developing studies to understand at the molecular level different cell signaling pathways involved in cancer development. In this work, we present a model of the PI3K/Akt/mTOR pathway, which plays a key role in cell cycle regulation and is related to cell survival, proliferation, and growth in cancer, as well as resistance to antitumor therapies, so finding drugs that act on this pathway is ideal to propose a new adjuvant treatment. The aim of this work was to model, simulate and predict in silico using the Big Data-Cellulat platform the possible targets in the PI3K/Akt/mTOR pathway on which the Opuntia joconostle extract acts, as well as to indicate the concentration range to be used to find the mean lethal dose in in vitro experiments on breast cancer cells. The in silico results show that, in a cancer cell, the activation of JAK and STAT, as well as PI3K and Akt is related to the effect of cell proliferation, angiogenesis, and inhibition of apoptosis, and that the extract of O. joconostle has an antiproliferative effect on breast cancer cells by inhibiting cell proliferation, regulating the cell cycle and inhibiting apoptosis through this signaling pathway. In vitro it was demonstrated that the extract shows an antiproliferative effect, causing the arrest of cells in the G2/M phase of the cell cycle. Therefore, it is concluded that the use of in silico tools is a valuable method to perform virtual experiments and discover new treatments. The use of this type of model supports in vitro experimentation, reducing the costs and number of experiments in the real laboratory.","PeriodicalId":35418,"journal":{"name":"Cancer Informatics","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42815755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
A Clinical Decision Support System for Increasing Compliance with Protocols in Chemotherapy of Children with Acute Lymphoblastic Leukemia 提高儿童急性淋巴细胞白血病化疗方案依从性的临床决策支持系统
IF 2 Q2 MATHEMATICAL & COMPUTATIONAL BIOLOGY Pub Date : 2022-01-01 DOI: 10.1177/11769351221084812
H. Moghaddasi, Rezvan Rahimi, Alireza Kazemi, Khadijeh Arjmandi Rafsanjani, G. Bahoush, Forough Rahimi
Objective: In this survey, a protocol-based Chemotherapy Prescription Decision Support System (CPDSS) was designed and evaluated to reduce medication errors in the chemotherapy process of children with ALL. Methods: The CPDSS algorithm was extracted by the software development team based on the protocol used by doctors to treat children with ALL. The ASP.Net MVC and SQL Server 2016 programming languages were used to develop the system. A 3-step evaluation (technical, retrospective, and user satisfaction) was performed on CPDSS designed at 2 children’s hospitals in Tehran. The data were analyzed using descriptive statistics. At the technical evaluation step, users provided recommendations included in the system. Results: In the retrospective CPDSS evaluation step, 1281 prescribed doses of the drugs related to 30 patients were entered into the system. CPDSS detected 735 cases of protocol deviations and 57 (95%, CI = 1.25-2.55) errors in prescribed chemotherapy for children with ALL. In the user satisfaction evaluation, the users approved two dimensions of the user interface and functionality of the system. Conclusions: With the provision of alerts, the CPDSS can help increase compliance with chemotherapy protocols and decrease the chemotherapy prescribing errors that can improve patient safety.
目的:设计并评价基于协议的化疗处方决策支持系统(CPDSS),以减少ALL患儿化疗过程中的用药错误。方法:由软件开发团队根据医生治疗ALL患儿的方案提取CPDSS算法。ASP。系统的开发采用了。Net MVC和SQL Server 2016编程语言。对德黑兰两家儿童医院设计的CPDSS进行了三步评估(技术、回顾性和用户满意度)。数据采用描述性统计进行分析。在技术评价阶段,用户提供的建议被纳入系统。结果:在回顾性CPDSS评价步骤中,系统共录入了涉及30例患者的1281个处方剂量。CPDSS检测到735例方案偏差和57例(95% CI = 1.25-2.55)急性淋巴细胞白血病儿童处方化疗错误。在用户满意度评价中,用户对系统的用户界面和功能两个维度进行了认可。结论:CPDSS可提高患者对化疗方案的依从性,减少化疗处方错误,提高患者安全。
{"title":"A Clinical Decision Support System for Increasing Compliance with Protocols in Chemotherapy of Children with Acute Lymphoblastic Leukemia","authors":"H. Moghaddasi, Rezvan Rahimi, Alireza Kazemi, Khadijeh Arjmandi Rafsanjani, G. Bahoush, Forough Rahimi","doi":"10.1177/11769351221084812","DOIUrl":"https://doi.org/10.1177/11769351221084812","url":null,"abstract":"Objective: In this survey, a protocol-based Chemotherapy Prescription Decision Support System (CPDSS) was designed and evaluated to reduce medication errors in the chemotherapy process of children with ALL. Methods: The CPDSS algorithm was extracted by the software development team based on the protocol used by doctors to treat children with ALL. The ASP.Net MVC and SQL Server 2016 programming languages were used to develop the system. A 3-step evaluation (technical, retrospective, and user satisfaction) was performed on CPDSS designed at 2 children’s hospitals in Tehran. The data were analyzed using descriptive statistics. At the technical evaluation step, users provided recommendations included in the system. Results: In the retrospective CPDSS evaluation step, 1281 prescribed doses of the drugs related to 30 patients were entered into the system. CPDSS detected 735 cases of protocol deviations and 57 (95%, CI = 1.25-2.55) errors in prescribed chemotherapy for children with ALL. In the user satisfaction evaluation, the users approved two dimensions of the user interface and functionality of the system. Conclusions: With the provision of alerts, the CPDSS can help increase compliance with chemotherapy protocols and decrease the chemotherapy prescribing errors that can improve patient safety.","PeriodicalId":35418,"journal":{"name":"Cancer Informatics","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42461319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cancer Informatics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1